{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:21:40Z","timestamp":1781421700642,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T00:00:00Z","timestamp":1089936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s00213-004-1957-9","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T09:39:42Z","timestamp":1089884382000},"page":"280-288","source":"Crossref","is-referenced-by-count":84,"title":["Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial"],"prefix":"10.1007","volume":"177","author":[{"given":"Murray B.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bystritsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,16]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.179.1.15","volume":"179","author":"Allgulander","year":"2001","unstructured":"Allgulander C, Hackett D, Salinas E (2001) Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder. Br J Psychiatry 179:15?22","journal-title":"Br J Psychiatry"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.175.2.120","volume":"175","author":"Baldwin","year":"1999","unstructured":"Baldwin D, Bobes J, Stein DJ, Scharwachter I, Faure M (1999) Paroxetine in social phobia\/social anxiety disorder?randomised, double-blind, placebo-controlled study. Br J Psychiatry 175:120?126","journal-title":"Br J Psychiatry"},{"key":"CR3","first-page":"54","volume":"59","author":"Ballenger","year":"1999","unstructured":"Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Bobes J, Beidel DC, Ono Y, Westenberg HGM (1999) Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 59:54?60","journal-title":"J Clin Psychiatry"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1192\/bjp.176.4.379","volume":"176","author":"Connor","year":"2000","unstructured":"Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa EB, Weisler RH (2000) Psychometric properties of the Social Phobia Inventory (SPIN): a new self-rating scale. Br J Psychiatry 176:379?386","journal-title":"Br J Psychiatry"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4088\/JCP.v64n0109","volume":"64","author":"Doyle","year":"2003","unstructured":"Doyle AC, Pollack MH (2003) Establishment of remission criteria for anxiety disorders. J Clin Psychiatry 64:40?45","journal-title":"J Clin Psychiatry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1001\/jama.283.23.3082","volume":"283","author":"Gelenberg","year":"2000","unstructured":"Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E (2000) Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. JAMA 283:3082?3088","journal-title":"JAMA"},{"key":"CR7","doi-asserted-by":"crossref","unstructured":"Guy W (1976) ECDEU Assessment manual for psychopharmacology (revised). DHEW Publications (ADM), Rockville, Md., National Institute for Mental Health","DOI":"10.1037\/e591322011-001"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56?62","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","volume":"55","author":"Heimberg","year":"1998","unstructured":"Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF (1998) Cognitive behavioral group therapy versus phenelzine therapy for social phobia. Arch Gen Psychiatry 55:1133?1141","journal-title":"Arch Gen Psychiatry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S0033291798007879","volume":"29","author":"Heimberg","year":"1999","unstructured":"Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR (1999) Psychometric properties of the Liebowitz social anxiety scale. Psychol Med 29:199?212","journal-title":"Psychol Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S003329170300881X","volume":"34","author":"Issakidis","year":"2004","unstructured":"Issakidis C, Sanderson K, Corry J, Andrews G, Lapsley H (2004) Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychol Med 34:19?35","journal-title":"Psychol Med"},{"key":"CR12","unstructured":"Kapczinski F, Lima MS, Souza JS, Schmitt R (2003) Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev CD003592"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1176\/appi.ajp.158.12.1999","volume":"158","author":"Katzelnick","year":"2001","unstructured":"Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP (2001) Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 158:1999?2007","journal-title":"Am J Psychiatry"},{"key":"CR14","first-page":"767","volume":"31","author":"Kelsey","year":"1995","unstructured":"Kelsey JE (1995) Venlafaxine in social phobia. Psychopharmacol Bull 31:767?771","journal-title":"Psychopharmacol Bull"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1176\/ajp.155.5.613","volume":"155","author":"Kessler","year":"1998","unstructured":"Kessler RC, Stein MB, Berglund PA (1998) Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 155:613?619","journal-title":"Am J Psychiatry"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S0033291799008375","volume":"29","author":"Kessler","year":"1999","unstructured":"Kessler RC, Stang P, Wittchen H-U, Stein MB, Walters EE (1999) Lifetime comorbidities between social phobia and mood disorders in the US National Comorbidity Survey. Psychol Med 29:555?567","journal-title":"Psychol Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004714-200206000-00005","volume":"22","author":"Kobak","year":"2002","unstructured":"Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ (2002) Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 22:257?262","journal-title":"J Clin Psychopharmacol"},{"key":"CR18","first-page":"474","volume":"32","author":"Leon","year":"1996","unstructured":"Leon AC, Olfson M, Portera L, Farber L, Sheehan DV (1996) Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Psychopharmacol Bull 32:474","journal-title":"Psychopharmacol Bull"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.49.4.290","volume":"49","author":"Liebowitz","year":"1992","unstructured":"Liebowitz MR, Schneier FR, Campeas R, Hollander E, Hatterer J, Fyer AJ, Gorman JM, Papp L, Davies S, Gully R, Klein DF (1992) Phenelzine versus atenolol in social phobia. Arch Gen Psychiatry 49:290?300","journal-title":"Arch Gen Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4088\/JCP.v63n0113","volume":"63","author":"Liebowitz","year":"2002","unstructured":"Liebowitz MR, Stein MB, Tancer ME, Carpenter D, Oakes R, Pitts CD (2002) A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treament of generalized social anxiety disorder. J Clin Psychiatry 63:66?74","journal-title":"J Clin Psychiatry"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4088\/JCP.v64n0708","volume":"64","author":"Liebowitz","year":"2003","unstructured":"Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, Fayyad R, Clary CM (2003) Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study. J Clin Psychiatry 64:785?792","journal-title":"J Clin Psychiatry"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archpsyc.1996.01830020077009","volume":"53","author":"Magee","year":"1996","unstructured":"Magee WJ, Eaton WW, Wittchen H-U, McGonagle KA, Kessler RC (1996) Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 53:159?168","journal-title":"Arch Gen Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/appi.ajp.157.5.669","volume":"157","author":"Mendlowicz","year":"2000","unstructured":"Mendlowicz MV, Stein MB (2000) Quality of life in individuals with anxiety disorders. Am J Psychiatry 157:669?682","journal-title":"Am J Psychiatry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-3223(02)01671-2","volume":"53","author":"Michelson","year":"2003","unstructured":"Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D (2003) Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53:112?120","journal-title":"Biol Psychiatry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353?365","journal-title":"Pharmacoeconomics"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1176\/appi.ajp.157.6.968","volume":"157","author":"Rickels","year":"2000","unstructured":"Rickels K, Pollack MH, Sheehan D, Haskins JT (2000) Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 157:968?974","journal-title":"Am J Psychiatry"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/bmj.327.7414.515","volume":"327","author":"Schneier","year":"2003","unstructured":"Schneier FR (2003) Social anxiety disorder. BMJ 327:515?516","journal-title":"BMJ"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpsyc.1992.01820040034004","volume":"49","author":"Schneier","year":"1992","unstructured":"Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992) Social phobia: comorbidity and morbidity in an epidemiological sample. Arch Gen Psychiatry 49:282?288","journal-title":"Arch Gen Psychiatry"},{"key":"CR29","first-page":"322","volume":"55","author":"Schneier","year":"1994","unstructured":"Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, Street L, Del Bene D, Liebowitz MR (1994) Functional impairment in social phobia. J Clin Psychiatry 55:322?331","journal-title":"J Clin Psychiatry"},{"key":"CR30","first-page":"244","volume":"65","author":"Seedat","year":"2004","unstructured":"Seedat S, Stein MB (2004) Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. J Clin Psychiatry 65:244?248","journal-title":"J Clin Psychiatry"},{"key":"CR31","first-page":"22","volume":"59","author":"Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janaversus J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22?33","journal-title":"J Clin Psychiatry"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.149.4.464","volume":"149","author":"Solyom","year":"1986","unstructured":"Solyom L, Ledwidge B, Solyom C (1986) Delineating social phobia. Br J Psychiatry 149:464?470","journal-title":"Br J Psychiatry"},{"key":"CR33","first-page":"185","volume":"26","author":"Stein","year":"2001","unstructured":"Stein MB, Gorman JM (2001) Unmasking social anxiety disorder. J Psychiatry Neurosci 26:185?189","journal-title":"J Psychiatry Neurosci"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1176\/appi.ajp.157.10.1606","volume":"157","author":"Stein","year":"2000","unstructured":"Stein MB, Kean Y (2000) Disability and quality of life in social phobia. Am J Psychiatry 157:1606?1613","journal-title":"Am J Psychiatry"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","volume":"280","author":"Stein","year":"1998","unstructured":"Stein MB, Liebowitz MR, Lydiard RB, Bushnell W, Gergel IP (1998) Paroxetine treatment of generalized social anxiety disorder (social phobia): a randomized controlled trial. JAMA 280:708?713","journal-title":"J Am Med Assoc"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1176\/ajp.156.5.756","volume":"156","author":"Stein","year":"1999","unstructured":"Stein MB, Fyer AJ, Davidson JRT, Pollack MH, Wiita B (1999a) Fluvoxamine in social phobia (social anxiety disorder): a double-blind, placebo-controlled clinical study. Am J Psychiatry 156:756?760","journal-title":"Am J Psychiatry"},{"key":"CR37","first-page":"514","volume":"48","author":"Stein","year":"1999","unstructured":"Stein MB, McQuaid JR, Laffaye C, McCahill ME (1999b) Social phobia in the primary care medical setting. J Fam Pract 48:514?519","journal-title":"J Fam Pract"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archpsyc.57.11.1046","volume":"57","author":"Stein","year":"2000","unstructured":"Stein MB, Torgrud LJ, Walker JR (2000) Social phobia symptoms, subtypes and severity: findings from a community survey. Arch Gen Psychiatry 57:1046?1052","journal-title":"Arch Gen Psychiatry"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archpsyc.58.3.251","volume":"58","author":"Stein","year":"2001","unstructured":"Stein MB, Fuetsch M, Muller N, H\ufffdfler M, Lieb R, Wittchen H-U (2001a) Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. Arch Gen Psychiatry 58:251?256","journal-title":"Arch Gen Psychiatry"},{"key":"CR40","first-page":"1727","volume":"158","author":"Stein","year":"2001","unstructured":"Stein MB, Sareen J, Hami S, Chao J (2001b) Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry 158:1727","journal-title":"Am J Psychiatry"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archpsyc.59.12.1111","volume":"59","author":"Stein","year":"2002","unstructured":"Stein DJ, Versiani M, Hair T, Kumar R (2002) Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Arch Gen Psychiatry 59:1111?1118","journal-title":"Arch Gen Psychiatry"},{"key":"CR42","doi-asserted-by":"crossref","unstructured":"Stein MB, Sherbourne CD, Craske MG, Means-Christensen A, Bystritsky A, Katon W, Sullivan G, Roy-Byrne PP (2004) Quality of care for primary care patients with anxiety disorders. Am J Psychiatry (in press)","DOI":"10.1176\/appi.ajp.161.12.2230"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archpsyc.59.3.233","volume":"59","author":"Thase","year":"2002","unstructured":"Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, Lavange LM, Klein DN, Fawcett J, Harrison W (2002) Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry 59:233?239","journal-title":"Arch Gen Psychiatry"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1176\/appi.ajp.158.2.275","volume":"158","author":"Van","year":"2001","unstructured":"Van Ameringen M, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, Johnston DG, Lavalle Y-J, Nandy S, Pecknold JC, Hadrava V, Swinson RP (2001) Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry 158:275?281","journal-title":"Am J Psychiatry"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00004714-200012000-00009","volume":"20","author":"Walker","year":"2000","unstructured":"Walker JR, Van Ameringen MA, Swinson R, Bowen RC, Chokka PR, Goldner E, Johnston DC, Lavallie YJ, Nandy S, Pecknold JC, Hadrava V, Lane RM (2000) Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment. J Clin Psychopharmacol 20:636?644","journal-title":"J Clin Psychopharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1957-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-1957-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-1957-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:18:15Z","timestamp":1682727495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-1957-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,16]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-1957-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,16]]}}}